Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1418
H.R.1418: Animal Drug and Animal Generic Drug User Fee Amendments of 2023
About This Bill
- Introduced March 7, 2023
- Latest Major Action Sept. 20, 2023
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Versions
- Placed on Calendar Senate - Sept. 20, 2023
- Engrossed in House - July 17, 2023
- Reported in House - June 9, 2023
- Introduced in House - March 7, 2023
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Sept. 20, 2023 |
Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
|
July 18, 2023 |
Received in the Senate.
|
July 17, 2023 |
Motion to reconsider laid on the table Agreed to without objection.
|
July 17, 2023 |
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
|
July 17, 2023 |
DEBATE - The House proceeded with forty minutes of debate on H.R. 1418.
|
July 17, 2023 |
Considered under suspension of the rules.
|
July 17, 2023 |
Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
|
July 17, 2023 |
Voice Vote in the HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3620-3623) |
July 17, 2023 |
Considered under suspension of the rules. (consideration: CR H3620-3624)
|
June 9, 2023 |
Placed on the Union Calendar, Calendar No. 80.
|
June 9, 2023 |
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-104.
|
May 24, 2023 |
Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
|
May 24, 2023 |
Committee Consideration and Mark-up Session Held.
|
May 17, 2023 |
Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 0 .
|
May 17, 2023 |
Subcommittee Consideration and Mark-up Session Held.
|
March 17, 2023 |
Referred to the Subcommittee on Health.
|
March 7, 2023 |
Referred to the House Committee on Energy and Commerce.
|
March 7, 2023 |
Introduced in the House by Greg Pence (R-Ind.) |